Today: 10 June 2026
Tesla stock slips as U.S. safety probe on Full Self-Driving gets a new deadline

Tesla stock slips as U.S. safety probe on Full Self-Driving gets a new deadline

New York, January 16, 2026, 09:33 EST — Regular session underway

  • Tesla shares slipped roughly 0.2% early Friday, adding to a volatile week
  • U.S. regulators have extended Tesla’s deadline to respond to inquiries about its Full Self-Driving system
  • Investors are eyeing the Jan. 28 earnings report for fresh details on margins and software revenue

Tesla shares slipped in early Friday trading after U.S. auto safety regulators gave the company extra time to respond to a federal investigation into its Full Self-Driving system.

The extension prolongs regulatory uncertainty around a crucial element of Tesla’s investor appeal: its software and driver-assistance features, which promise recurring revenue as the electric-vehicle market evolves and price cuts take effect. With earnings less than two weeks away, the timing is far from ideal.

The National Highway Traffic Safety Administration pushed back Tesla’s deadline for critical responses to Feb. 23. The extension came after Tesla requested extra time to go over documents related to alleged traffic-law breaches while Full Self-Driving was active.

Tesla slipped 0.2% to $438.57, after opening at $441.07. The stock had closed Thursday almost unchanged.

Regulators are reviewing complaints, crash reports, and other related materials tied to the system. NHTSA said it has logged 62 complaints and found additional media coverage and crash reports that might be linked to the problem, the agency said.

The extension comes just days after CEO Elon Musk announced Tesla will switch Full Self-Driving (Supervised) to a subscription-only model starting Feb. 14. Currently, U.S. owners can either pay a one-time fee of $8,000 or opt for a $99 monthly subscription, Reuters reported.

Musk was straightforward on X: “Tesla will stop selling FSD after Feb 14.” https://electrek.co/2026/01/14/tesla-tsla-…

Full Self-Driving is a driver-assistance system that still demands the driver’s attention. While the software manages tasks like lane changes and stopping at traffic lights, the driver must remain ready to intervene.

Tesla will release its quarterly earnings after the market closes on Jan. 28. The company also plans a Q&A webcast later that day, it said.

Rivian and Lucid slipped early Friday, adding pressure on Tesla amid a broader tech selloff.

The downside is straightforward: stricter regulations might force Tesla to alter how it markets or rolls out its driver-assistance features, potentially leading to expensive fixes. The move to subscriptions brings risk too, especially if drivers resist monthly fees or if increased scrutiny slows adoption.

Traders are now focused on a tightly packed calendar: updates from regulators before the Feb. 23 deadline, the shift to subscription-only access on Feb. 14, and Tesla’s Jan. 28 earnings. They’ll be looking for clues that software sales can help cushion the blow from weaker car demand.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
LSEG share price today: London Stock Exchange Group dips after 24/7 Digital Settlement House debut, AWS pact
Previous Story

LSEG share price today: London Stock Exchange Group dips after 24/7 Digital Settlement House debut, AWS pact

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees
Next Story

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees

Go toTop